Cardioprotection by systemic dosing of thymosin beta four following ischemic myocardial injury

Thymosin beta 4 (Tβ4) was previously shown to reduce infarct size and improve contractile performance in chronic myocardial ischemic injury via two phases of action: an acute phase, just after injury, when Tβ4 preserves ischemic myocardium via antiapoptotic or anti-inflammatory mechanisms; and a chr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bao, Weike, Ballard, Victoria L., Needle, Saul, Hoang, Bao, Lenhard, Stephen C., Tunstead, James R., Jucker, Beat M., Willette, Robert N., Pipes, G. Teg
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2013
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3843122/
https://ncbi.nlm.nih.gov/pubmed/24348421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2013.00149
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak